| Indicators | Browse All

VolitionRx Limited (VNRX)

Healthcare | Medical Devices | Henderson, United States | NYSE American
1.30 USD -0.05 (-3.704%) ⇩ (July 13, 2026, 4 p.m. EDT)
After hours: 1.26 -0.04 (-0.040%) ⇩ (July 13, 2026, 7:20 p.m. EDT)

Short-term:★☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 5:15 a.m. EDT

The investment case for VolitionRx is currently broken by a catastrophic collapse in shareholder value and a deteriorating balance sheet. Over the last nine years, the stock has lost approximately 80% of its value, trading at a fraction of its historical worth despite a recent, albeit small, annual price recovery. Fundamentally, the company is bleeding cash with negative free cash flow of nearly $9.2 million and operating losses exceeding $20 million. The balance sheet is fragile, with debt of roughly $11.7 million outweighing cash reserves of just $3.1 million, resulting in a current ratio of only 0.33. This precarious financial state is reflected in the market's reaction: the options chain is dominated by put buyers seeking insurance against further drops, while the statistical forecast models predict a continued decline over the next 45 days. Despite a 'Buy' recommendation from analysts and a partnership with Sysmex, the underlying economics—negative earnings, massive debt, and eroding equity—make this a high-risk speculative vehicle rather than a viable investment.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.161051
AutoTheta0.240227
AutoETS0.332351
MSTL0.341807

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 39%
H-stat 0.73
Ljung-Box p 0.000
Jarque-Bera p 0.142
Excess Kurtosis -0.46
Attribute Value
Sector Healthcare
Revenue per Share 0.421
Market Cap 15,657,640
Forward P/E -1.13
Beta 1.12
Website https://volition.com

As of July 11, 2026, 5:15 a.m. EDT: Speculators are overwhelmingly positioning for downside protection rather than upside participation. Put volume and open interest significantly exceed call volume across all expirations, with notable new flow into the $2.5 strike puts for the August expiration. While there is some open interest in out-of-the-money calls ($5.00 strikes), the lack of call volume combined with heavy put positioning suggests a bearish sentiment and a fear of further decline.


Info Dump

Attribute Value
52 Week Change -0.9007353
Address1 1,489 West Warm Springs Road
Address2 Suite 110
All Time High 185.6
All Time Low 1.17
Ask 0.0
Ask Size 400
Average Analyst Rating 1.6 - Buy
Average Daily Volume10 Day 224,290
Average Daily Volume3 Month 290,692
Average Volume 290,692
Average Volume10Days 224,290
Beta 1.115
Bid 0.0
Bid Size 200
Book Value -4.032
City Henderson
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 1.3
Current Ratio 0.333
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 1.37
Day Low 1.2699
Display Name VolitionRx
Earnings Call Timestamp End 1,778,848,200
Earnings Call Timestamp Start 1,778,848,200
Earnings Timestamp 1,778,788,800
Earnings Timestamp End 1,786,651,200
Earnings Timestamp Start 1,786,651,200
Ebitda -20,626,568
Ebitda Margins 0.0
Enterprise To Ebitda -0.875
Enterprise To Revenue 7.317
Enterprise Value 18,044,216
Eps Current Year -2.62
Eps Forward -1.15
Eps Trailing Twelve Months -4.09
Esg Populated 0
Exchange ASE
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 1.9402
Fifty Day Average Change -0.6402
Fifty Day Average Change Percent -0.329966
Fifty Two Week Change Percent -90.07353
Fifty Two Week High 16.0
Fifty Two Week High Change -14.7
Fifty Two Week High Change Percent -0.91875
Fifty Two Week Low 1.17
Fifty Two Week Low Change 0.13
Fifty Two Week Low Change Percent 0.11111111
Fifty Two Week Range 1.17 - 16.0
Financial Currency USD
First Trade Date Milliseconds 1,330,698,600,000
Float Shares 6,655,386
Forward Eps -1.15
Forward P E -1.1304348
Free Cashflow -9,201,276
Full Exchange Name NYSE American
Full Time Employees 67
Gmt Off Set Milliseconds -14,400,000
Gross Margins 1.0
Gross Profits 2,466,075
Has Pre Post Market Data 1
Held Percent Insiders 0.08623
Held Percent Institutions 0.20798
Implied Shares Outstanding 12,044,339
Industry Medical Devices
Industry Disp Medical Devices
Industry Key medical-devices
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,777,334,400
Last Split Factor 1:20
Long Business Summary VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.
Long Name VolitionRx Limited
Market us_market
Market Cap 15,657,640
Market State PREPRE
Max Age 86,400
Message Board Id finmb_113678246
Most Recent Quarter 1,774,915,200
Net Income To Common -24,598,042
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 16,092,706
Number Of Analyst Opinions 5
Open 1.41
Operating Cashflow -20,665,448
Operating Margins -5.42989
Payout Ratio 0.0
Phone 512 774 8930
Post Market Change -0.03999996
Post Market Change Percent -3.0769203
Post Market Price 1.26
Post Market Time 1,783,984,827
Previous Close 1.35
Price Eps Current Year -0.49618322
Price Hint 4
Price To Book -0.32242063
Price To Sales Trailing12 Months 6.349215
Profit Margins 0.0
Quick Ratio 0.247
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key buy
Recommendation Mean 1.6
Region US
Regular Market Change -0.0500001
Regular Market Change Percent -3.70371
Regular Market Day High 1.37
Regular Market Day Low 1.2699
Regular Market Day Range 1.2699 - 1.37
Regular Market Open 1.41
Regular Market Previous Close 1.35
Regular Market Price 1.3
Regular Market Time 1,783,972,800
Regular Market Volume 123,584
Return On Assets -1.53545
Revenue Growth 2.998
Revenue Per Share 0.421
Sand P52 Week Change 0.20847368
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 12,044,339
Shares Percent Shares Out 0.027
Shares Short 322,418
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 389,005
Short Name VolitionRX Limited
Short Percent Of Float 0.028199999
Short Ratio 0.89
Source Interval 15
State NV
Symbol VNRX
Target High Price 24.0
Target Low Price 4.0
Target Mean Price 16.966
Target Median Price 20.0
Total Cash 3,102,817
Total Cash Per Share 0.372
Total Debt 11,702,884
Total Revenue 2,466,075
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -4.09
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 5.05695
Two Hundred Day Average Change -3.7569501
Two Hundred Day Average Change Percent -0.7429281
Type Disp Equity
Volume 123,584
Website https://volition.com
Zip 89,014